LGALS3 and brain injury: In models of traumatic brain injury and spinal cord injury, treatment with anti-Gal-3 antibodies and the Gal-3 inhibitor GB1107, respectively, both led to significant reductions in the systemic levels of IL-1, IL-6, and TNF-α (Renet al., 2019;Yipet al., 2017).